Home / Going-concern warnings / OneMedNet Corp

3/5OneMedNet Corp (ONMD): Going-concern doubt

Filed 2025-08-13 路 Form 10-Q 路 Accession 0001641172-25-023557 nano

Market data

Price before filing: $4.68 (2025-08-12 close, split/dividend-adjusted)
Market cap at flag: $17.7M (2025-08-13) 路 Latest: $26.2M (2026-10-16)

What happened next

WindowONMDSPYvs SPY
30 days+80.1%+2.3%+77.8%2025-09-12
90 days+218.4%+6.6%+211.8%2025-11-11
180 days+49.4%+8.6%+40.8%2026-02-09

Return from the last close before the filing date to the first close on/after the window end. Pending windows have not fully elapsed. Past performance says nothing certain about the future.

Insider trading around this filing

90 days before the flag: 2 insiders bought $1.2M (3 purchases)
30 days after: 2 insiders bought $733K (12 purchases)

DateInsiderTypeSharesPriceValue10b5-1 planSource
2025-06-16Kosasa Thomas
Director
Purchase55,000$0.38$21KnoForm 4
2025-06-20Kosasa Thomas
Director
Purchase1,190,476$0.42$500KnoForm 4
2025-06-20Yu Jeffrey
Chief Medical Officer, Director
Purchase1,666,666$0.42$700KnoForm 4
2025-08-13: red flag filed
2025-08-19Yu Jeffrey
Chief Medical Officer, Director
Purchase16,500$0.77$13KnoForm 4
2025-08-21Yu Jeffrey
Chief Medical Officer, Director
Purchase15,000$0.77$12KnoForm 4
2025-08-25Yu Jeffrey
Chief Medical Officer, Director
Purchase13,300$0.75$10KnoForm 4
2025-08-26Yu Jeffrey
Chief Medical Officer, Director
Purchase173,350$0.69$120KnoForm 4
2025-08-27Yu Jeffrey
Chief Medical Officer, Director
Purchase21,374$0.69$15KnoForm 4
2025-08-28Yu Jeffrey
Chief Medical Officer, Director
Purchase17,000$0.80$14KnoForm 4
2025-08-29Kosasa Thomas
Director
Purchase581,395$0.86$500KnoForm 4
2025-08-29Yu Jeffrey
Chief Medical Officer, Director
Purchase10,890$0.82$9KnoForm 4
2025-09-02Yu Jeffrey
Chief Medical Officer, Director
Purchase24,319$0.85$21KnoForm 4
2025-09-03Yu Jeffrey
Chief Medical Officer, Director
Purchase11,670$0.81$9KnoForm 4
2025-09-04Yu Jeffrey
Chief Medical Officer, Director
Purchase11,810$0.87$10KnoForm 4
2025-09-05Yu Jeffrey
Chief Medical Officer, Director
Purchase2,100$0.86$2KnoForm 4

Open-market purchases and sales (Form 4 codes P and S) by officers, directors and 10% owners, by transaction date, from 2025-05-15 to 2025-09-12. Excludes option exercises, grants, gifts and tax withholding. Amended filings replace the originals; joint filings count once. Foreign private issuers do not file Form 4. Many insider sales are pre-scheduled (10b5-1 plans) and are not by themselves a sign of wrongdoing.

Verified excerpt

"At the time of these settlements, (1) the Company had negative cash flow from operations, historical losses, and a significant accumulated deficit that raised substantial doubt about the Company's ability to continue as a going concern, and (2) a concession was granted to the Company, as the fair value of the consideration received by the vendors was less than the net carrying value of the payables."

Quoted from the filing. Source

What this means

The filing states that substantial doubt exists about the company's ability to continue as a going concern: it may not have enough cash to last the next 12 months. Expect dilution, debt deals or worse. An auditor's going-concern paragraph is the strongest form of this warning.

Source: management disclosure in Form 10-Q (period 2025-06-30)

Why this score: quarterly (unaudited) disclosure

Read the original filing on SEC.gov →

Not investment advice. Automated summary; verify against the filing.

Get the weekly "Red Flags" newsletter

The week's most serious auditor changes, restatements, late filings and going-concern warnings, in plain English. Free. Unsubscribe anytime.

Subscribe to the newsletter →
The signup form didn't load here (often an ad or privacy blocker). This opens beehiiv's secure signup page.

Form not showing? Subscribe on beehiiv →

Newsletter delivered by beehiiv. See our privacy policy.